Sharda Cropchem (SHARDACROP) Q1 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 24/25 earnings summary
3 Feb, 2026Executive summary
Q1 FY2025 revenue grew 23% year-over-year to INR 785 crores (₹78,511 lakhs), driven by strong agrochemical segment performance, especially in Europe, which nearly doubled its contribution.
Agrochemical volumes rose 48.9% year-over-year, while non-agrochemical volumes declined 39% year-over-year.
Gross margins normalized to 29.2% in Q1 FY2025, up from 8.7% in Q1 FY24, with EBITDA margin at 11.3% and PAT at INR 27 crores (₹2,725 lakhs), reversing a loss of INR 89 crores last year.
Unaudited financial results for Q1 FY25 were approved, with both standalone and consolidated statements reviewed and an unmodified opinion from auditors.
Financial highlights
Revenue: INR 785 crores (₹78,511 lakhs) in Q1 FY2025 vs INR 638 crores in Q1 FY24 (23% growth).
Agrochemical revenue: INR 679 crores (₹67,926 lakhs, +43% YoY); non-agrochemical revenue: INR 106 crores (₹10,586 lakhs, -35% YoY).
Gross profit increased 311% to ₹228.9 crore, with gross margin at 29.2%.
EBITDA: INR 88 crores (11.3% margin) vs loss of INR 66 crores in Q1 FY24.
PAT: INR 27 crores (₹2,725 lakhs) vs loss of INR 89 crores (₹8,864 lakhs) in Q1 FY24; EPS at ₹3.02.
Outlook and guidance
Volume growth guidance for FY2025 remains at 15%-18%, with EBITDA margin guidance also at 15%-18%.
Management expects gradual price improvement in agrochemicals, with prices potentially reaching $30-$40 per unit by year-end.
Strategic focus on expanding sales force, strengthening distribution, and investing in product registrations to drive growth.
Normalized sales returns expected, with no abnormal returns seen in Q2 so far.
Management anticipates sustainable volume growth of 15%-20% as market stabilizes.
Latest events from Sharda Cropchem
- Record revenue and EBITDA growth in FY25, driven by strong volumes and margin recovery.SHARDACROP
Q3 24/253 Feb 2026 - Record PAT and revenue growth, margin gains, and Rs. 6.00 interim dividend declared.SHARDACROP
Q3 25/262 Feb 2026 - Q2 FY2025 revenue up 34% YoY, margins improved, and guidance set at 15%-18% growth for FY2025.SHARDACROP
Q2 24/2518 Jan 2026 - Q2 and H1 FY26 delivered strong revenue, profit, and margin growth, led by agrochemicals.SHARDACROP
Q2 25/2629 Dec 2025 - FY25 saw strong profit and margin growth, with over 15% top-line growth targeted for FY26.SHARDACROP
Q4 24/2518 Nov 2025 - Q1 FY26 saw 25% revenue growth, 67% EBITDA growth, and over 4x PAT, with strong global demand.SHARDACROP
Q1 25/2616 Nov 2025